Literature DB >> 29709628

Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity.

Rocco Marchitelli1, Marco Aiello2, Arnaud Cachia3, Mario Quarantelli4, Carlo Cavaliere1, Alfredo Postiglione5, Gioacchino Tedeschi6, Patrizia Montella6, Graziella Milan7, Marco Salvatore1, Elena Salvatore8, Jean Claude Baron9, Sabina Pappatà4.   

Abstract

Simultaneously evaluating resting-state brain glucose metabolism and intrinsic functional activity has potential to impact the clinical neurosciences of Alzheimer Disease (AD). Indeed, integrating such combined information obtained in the same physiological setting may clarify how impairments in neuroenergetic and neuronal function interact and contribute to the mechanisms underlying AD. The present study used this multimodality approach to investigate, by means of a hybrid PET/MR scanner, the coupling between glucose consumption and intrinsic functional activity in 23 patients with AD-related cognitive impairment ranging from amnestic mild cognitive impairment (MCI) to mild-moderate AD (aMCI/AD), in comparison with a group of 23 healthy elderly controls. Between-group (Controls > Patients) comparisons were conducted on data from both imaging modalities using voxelwise 2-sample t-tests, corrected for partial-volume effects, head motion, age, gender and multiple tests. FDG-PET/fMRI relationships were assessed within and across subjects using Spearman partial correlations for three different resting-state fMRI (rs-fMRI) metrics sensitive to AD: fractional amplitude of low frequency fluctuations (fALFF), regional homogeneity (ReHo) and group independent component analysis with dual regression (gICA-DR). FDG and rs-fMRI metrics distinguished aMCI/AD from controls according to spatial patterns analogous to those found in stand-alone studies. Within-subject correlations were comparable across the three rs-fMRI metrics. Correlations were overall high in healthy controls (ρ = 0.80 ± 0.04), but showed a significant 17% reduction (p < 0.05) in aMCI/AD patients (ρ = 0.67 ± 0.05). Positive across-subject correlations were overall moderate (ρ = 0.33 ± 0.07) and consistent across rs-fMRI metrics. These were confined around AD-target posterior regions for metrics of functional connectivity (ReHo and gICA-DR). In contrast, FDG/fALFF correlations were distributed in the frontal gyrus, thalami and caudate nuclei. Taken together, these results support the presence of bioenergetic coupling between glucose utilization and rapid transmission of neural information in healthy ageing, which is substantially reduced in aMCI/AD, suggesting that abnormal glucose utilization is in some way linked to communication breakdown among brain regions impacted by the underlying pathological process.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Brain functional MRI; Default mode network; Fludeoxyglucose PET; Intrinsic functional connectivity; Mild cognitive impairment

Mesh:

Substances:

Year:  2018        PMID: 29709628     DOI: 10.1016/j.neuroimage.2018.04.048

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  20 in total

Review 1.  Advances in simultaneous PET/MR for imaging neuroreceptor function.

Authors:  Christin Y Sander; Hanne D Hansen; Hsiao-Ying Wey
Journal:  J Cereb Blood Flow Metab       Date:  2020-03-13       Impact factor: 6.200

2.  The Relationship Among Glucose Metabolism, Cerebral Blood Flow, and Functional Activity: a Hybrid PET/fMRI Study.

Authors:  Jingjuan Wang; Haiyang Sun; Bixiao Cui; Hongwei Yang; Yi Shan; Chengyan Dong; Yufeng Zang; Jie Lu
Journal:  Mol Neurobiol       Date:  2021-02-01       Impact factor: 5.590

3.  Frontal lobe fALFF measured from resting-state fMRI as a prognostic biomarker in first-episode psychosis.

Authors:  Todd Lencz; Ashley Moyett; Miklos Argyelan; Anita D Barber; John Cholewa; Michael L Birnbaum; Juan A Gallego; Majnu John; Philip R Szeszko; Delbert G Robinson; Anil K Malhotra
Journal:  Neuropsychopharmacology       Date:  2022-10-05       Impact factor: 8.294

Review 4.  Spatial normalization and quantification approaches of PET imaging for neurological disorders.

Authors:  Teng Zhang; Shuang Wu; Xiaohui Zhang; Yiwu Dai; Anxin Wang; Hong Zhang; Mei Tian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-05-28       Impact factor: 10.057

5.  Differential Effects of 2-Deoxyglucose and Glucose Deprivation on 4-Hydroxynonenal Dependent Mitochondrial Dysfunction in Primary Neurons.

Authors:  Matthew Dodson; Gloria A Benavides; Victor Darley-Usmar; Jianhua Zhang
Journal:  Front Aging       Date:  2022-02-21

6.  Multimodal Neuroimaging Approach to Variability of Functional Connectivity in Disorders of Consciousness: A PET/MRI Pilot Study.

Authors:  Carlo Cavaliere; Sivayini Kandeepan; Marco Aiello; Demetrius Ribeiro de Paula; Rocco Marchitelli; Salvatore Fiorenza; Mario Orsini; Luigi Trojano; Orsola Masotta; Keith St Lawrence; Vincenzo Loreto; Blaine Alexander Chronik; Emanuele Nicolai; Andrea Soddu; Anna Estraneo
Journal:  Front Neurol       Date:  2018-10-18       Impact factor: 4.003

Review 7.  The Challenges of Diagnostic Imaging in the Era of Big Data.

Authors:  Marco Aiello; Carlo Cavaliere; Antonio D'Albore; Marco Salvatore
Journal:  J Clin Med       Date:  2019-03-06       Impact factor: 4.241

Review 8.  Evaluation of Functional Connectivity in the Brain Using Positron Emission Tomography: A Mini-Review.

Authors:  Tadashi Watabe; Jun Hatazawa
Journal:  Front Neurosci       Date:  2019-07-26       Impact factor: 4.677

Review 9.  Gliosis and Neurodegenerative Diseases: The Role of PET and MR Imaging.

Authors:  Carlo Cavaliere; Liberatore Tramontano; Dario Fiorenza; Vincenzo Alfano; Marco Aiello; Marco Salvatore
Journal:  Front Cell Neurosci       Date:  2020-04-02       Impact factor: 5.505

10.  Entrainment of Network Activity by Closed-Loop Microstimulation in Healthy Ambulatory Rats.

Authors:  Alberto Averna; Page Hayley; Maxwell D Murphy; Federico Barban; Jimmy Nguyen; Stefano Buccelli; Randolph J Nudo; Michela Chiappalone; David J Guggenmos
Journal:  Cereb Cortex       Date:  2021-10-01       Impact factor: 4.861

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.